Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.

The Journal of antimicrobial chemotherapy - 1 Mar 2002

Yamakawa Tetsumi, Mitsuyama Junichi, Hayashi Kazuya

Abstract excerpt

The in vitro and in vivo activity of T-3912, a novel non-fluorinated topical quinolone, was compared with that of nadifloxacin, ofloxacin, levofloxacin, clindamycin, erythromycin and gentamicin. The in vitro activity of T-3912 against methicillin-susceptible Staphylococcus aureus, ofloxacin-resistant and methicillin-resistant S. aureus, Staphylococcus epidermidis, ofloxacin-resistant S. epidermidis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clindamycin
Share to DNA Topoisomerase IV
Share to Gentamicins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Levofloxacin

Share to Ofloxacin

Share to Staphylococcal Skin Infections

Share to Staphylococcus epidermidis

Share to Topoisomerase II Inhibitors

Source

Identifiers

PMID: 11864945
DOI: 10.1093/jac/49.3.455

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.PMID 11864945Read ↗

Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.Semantic proximity Read ↗

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.Semantic proximity Read ↗

Updated Review on Clinically-Relevant Properties of DelafloxacinSemantic proximity Read ↗

TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.Semantic proximity Read ↗

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Semantic proximity Read ↗

Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.Semantic proximity Read ↗

In Vitro and In Vivo Antibacterial Activities of DC-159a, a New FluoroquinoloneSemantic proximity Read ↗

In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Semantic proximity Read ↗

Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.Semantic proximity Read ↗

In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.Semantic proximity Read ↗

Antibacterial Activity of Gatifloxacin (AM-1155, CG5501, BMS-206584), a Newly Developed Fluoroquinolone, against Sequentially Acquired Quinolone-Resistant Mutants and the norA Transformant of Staphylococcus aureusSemantic proximity Read ↗

Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.